Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...

Bristol-Myers Squibb and BioNTech are launching ROSETTA HCC-206, an early-stage clinical trial in advanced or inoperable liver cancer (hepatocellular carcinoma). The study, officially titled “ROSETTA ...

DENVER, Colo. (Ivanhoe Newswire) – More than 40,000 people will be told they have liver cancer this year. Thirty thousand will die from the disease. It’s considered the leading cause of cancer deaths ...

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. PFE’s New Liver Cancer Trial: Early Signal to Watch The study, officially ...

Prevention and treatment advances are reducing the number of new liver cancer patients and narrowing survival gaps among ...

Stanford University scientists have found that erythropoietin (EPO), a protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells also plays a surprising, ...

What if cutting off a tumor’s fat supply could also rally the immune system to join the fight? Liver cancer fueled by fatty liver disease is on the rise, and with low survival rates, new treatment ...

An experimental vaccine has saved lives in an early clinical trial for a rare form of liver cancer that primarily affects younger patients, researchers with Johns Hopkins Kimmel Cancer Center ...

UChicago Medicine is using a new technology to destroy liver tumors without radiation, chemotherapy or even cutting the skin. Called histotripsy, it destroys tumors using sound waves. Amber Sikes was ...

Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound waves. For some patients with liver cancer, they could be spared invasive ...

Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ...

Five-month-old Hazel Ward is battling a rare and aggressive liver cancer, and doctors say a transplant is now her best chance ...